BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 35372412)

  • 1. Gene Variation at Immunomodulatory and Cell Adhesion Molecules Loci Impacts Primary Sjögren's Syndrome.
    Casadó-Llombart S; Gheitasi H; Ariño S; Consuegra-Fernández M; Armiger-Borràs N; Kostov B; Ramos-Casals M; Brito-Zerón P; Lozano F
    Front Med (Lausanne); 2022; 9():822290. PubMed ID: 35372412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene variation impact on prostate cancer progression: Lymphocyte modulator, activation, and cell adhesion gene variant contribution.
    Casadó-Llombart S; Ajami T; Consuegra-Fernández M; Carreras E; Aranda F; Armiger N; Alcaraz A; Mengual L; Lozano F
    Prostate; 2022 Oct; 82(14):1331-1337. PubMed ID: 35767366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental and genetic evidence for the impact of
    Casadó-Llombart S; Velasco-de Andrés M; Català C; Leyton-Pereira A; Gutiérrez-Cózar R; Suárez B; Armiger N; Carreras E; Esteller M; Ricart E; Ordás I; Gisbert JP; Chaparro M; Esteve M; Márquez L; Busquets D; Iglesias E; García-Planella E; Martín-Arranz MD; Lohmann J; Ayata CK; Niess JH; Engel P; Panés J; Salas A; Domènech E; Lozano F;
    Front Immunol; 2022; 13():966184. PubMed ID: 36211446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale for treating primary Sjögren's syndrome patients with an anti-CD6 monoclonal antibody (Itolizumab).
    Le Dantec C; Alonso R; Fali T; Montero E; Devauchelle V; Saraux A; Pers JO; Renaudineau Y
    Immunol Res; 2013 Jul; 56(2-3):341-7. PubMed ID: 23576060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant expression of CD6 on B-cell subsets from patients with Sjögren's syndrome.
    Alonso R; Buors C; Le Dantec C; Hillion S; Pers JO; Saraux A; Montero E; Marianowski R; Loisel S; Devauchelle V; Youinou P; Renaudineau Y
    J Autoimmun; 2010 Dec; 35(4):336-41. PubMed ID: 20810246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic and experimental evidence for the involvement of the CD6 lymphocyte receptor in psoriasis.
    Consuegra-Fernández M; Julià M; Martínez-Florensa M; Aranda F; Català C; Armiger-Borràs N; Arias MT; Santiago F; Guilabert A; Esteve A; Muñoz C; Ferrándiz C; Carrascosa JM; Pedrosa E; Romaní J; Alsina M; Mascaró-Galy JM; Lozano F
    Cell Mol Immunol; 2018 Oct; 15(10):898-906. PubMed ID: 29225340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of CD6 function through interaction with Galectin-1 and -3.
    Escoda-Ferran C; Carrasco E; Caballero-Baños M; Miró-Julià C; Martínez-Florensa M; Consuegra-Fernández M; Martínez VG; Liu FT; Lozano F
    FEBS Lett; 2014 Aug; 588(17):2805-13. PubMed ID: 24945728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of Evolutionary Selected Immune Gene Polymorphism to Immune-Related Disorders: The Case of Lymphocyte Scavenger Receptors
    Casadó-Llombart S; Velasco-de Andrés M; Català C; Leyton-Pereira A; Lozano F; Bosch E
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34070159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale for Targeting CD6 as a Treatment for Autoimmune Diseases.
    Alonso-Ramirez R; Loisel S; Buors C; Pers JO; Montero E; Youinou P; Renaudineau Y
    Arthritis; 2010; 2010():130646. PubMed ID: 22076177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fine mapping and functional analysis of the multiple sclerosis risk gene CD6.
    Swaminathan B; Cuapio A; Alloza I; Matesanz F; Alcina A; García-Barcina M; Fedetz M; Fernández O; Lucas M; Orpez T; Pinto-Medel MJ; Otaegui D; Olascoaga J; Urcelay E; Ortiz MA; Arroyo R; Oksenberg JR; Antigüedad A; Tolosa E; Vandenbroeck K
    PLoS One; 2013; 8(4):e62376. PubMed ID: 23638056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD166 expression, characterization, and localization in salivary epithelium: implications for function during sialoadenitis.
    Abidi SM; Saifullah MK; Zafiropulos MD; Kaput C; Bowen MA; Cotton C; Singer NG
    J Clin Immunol; 2006 Jan; 26(1):12-21. PubMed ID: 16418799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble CD5 and CD6: Lymphocytic Class I Scavenger Receptors as Immunotherapeutic Agents.
    Velasco-de Andrés M; Casadó-Llombart S; Català C; Leyton-Pereira A; Lozano F; Aranda F
    Cells; 2020 Dec; 9(12):. PubMed ID: 33287301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ectodomains of the lymphocyte scavenger receptors CD5 and CD6 interact with tegumental antigens from Echinococcus granulosus sensu lato and protect mice against secondary cystic echinococcosis.
    Mourglia-Ettlin G; Miles S; Velasco-De-Andrés M; Armiger-Borràs N; Cucher M; Dematteis S; Lozano F
    PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006891. PubMed ID: 30500820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrahepatic activated leukocyte cell adhesion molecule induces CD6
    Qian Q; Cui N; Huang B; Zhao Y; Liu Q; Hu M; Li B; Wang Q; Miao Q; You Z; Ma X; Tang R
    Front Immunol; 2022; 13():967944. PubMed ID: 36159854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The amino-terminal immunoglobulin-like domain of activated leukocyte cell adhesion molecule binds specifically to the membrane-proximal scavenger receptor cysteine-rich domain of CD6 with a 1:1 stoichiometry.
    Bowen MA; Bajorath J; Siadak AW; Modrell B; Malacko AR; Marquardt H; Nadler SG; Aruffo A
    J Biol Chem; 1996 Jul; 271(29):17390-6. PubMed ID: 8663238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Link Between CD6 and Autoimmunity: Genetic and Cellular Associations.
    Kofler DM; Farkas A; von Bergwelt-Baildon M; Hafler DA
    Curr Drug Targets; 2016; 17(6):651-65. PubMed ID: 26844569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifaceted effects of soluble human CD6 in experimental cancer models.
    Simões IT; Aranda F; Casadó-Llombart S; Velasco-de Andrés M; Català C; Álvarez P; Consuegra-Fernández M; Orta-Mascaró M; Merino R; Merino J; Alberola-Ila J; González-Aseguinolaza G; Carreras E; Martínez V; Lozano F
    J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32217757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical Role of CD6highCD4+ T Cells in Driving Th1/Th17 Cell Immune Responses and Mucosal Inflammation in IBD.
    Ma C; Wu W; Lin R; Ge Y; Zhang C; Sun S; Cong Y; Li X; Liu Z
    J Crohns Colitis; 2019 Mar; 13(4):510-524. PubMed ID: 30395204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease activity and damage in patients with primary Sjogren's syndrome: Prognostic value of salivary gland ultrasonography.
    Milic V; Colic J; Cirkovic A; Stanojlovic S; Damjanov N
    PLoS One; 2019; 14(12):e0226498. PubMed ID: 31891590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of mouse ALCAM (CD166): the CD6-binding domain is conserved in different homologs and mediates cross-species binding.
    Bowen MA; Bajorath J; D'Egidio M; Whitney GS; Palmer D; Kobarg J; Starling GC; Siadak AW; Aruffo A
    Eur J Immunol; 1997 Jun; 27(6):1469-78. PubMed ID: 9209500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.